Text Size

Stimulation ImplantsRSS

Add your listing here

VNS Therapy

May 27 2010 - Cyberonics, Inc. announced the results of a multicenter, double-blind, randomized dosing study which showed a consistent, sustained and clinically meaningful decrease in depression symptoms across all treatment groups as measured by multiple validated depression assessment scales. Four physician-rated depression scales and one patient-rated depression scale used in thi ...
Read More...

ManufacturerCyberonics
Hits720
Updated31 December 2010
Soletra® - Activa® Therapy

On May 21, 2009, Medtronic, announced the U.S. FDA had approved Activa® RC and Activa PC. The deep brain stimulation (DBS) devices are available for the treatment of the symptoms of advanced Parkinson’s disease and essential tremor.  Medtronic DBS Therapy delivers small electrical pulses to precisely targeted areas within one or both sides of the brain to help patients achieve gr ...
Read More...

ManufacturerMedtronic
Hits807
Updated30 March 2010
Activa® SC

Medtronic provides the industry’s only complete portfolio of next-generation DBS systems to meet individual patient needs, all in a single programming platform. The advanced programming features of Activa devices provide clinicians with greater ability to fine-tune stimulation and customize their patients’ therapy, which may help patients reach optimized settings sooner.

ManufacturerMedtronic
Hits655
Updated17 March 2011
Brio™

One Lillehei Plaza, St. Paul, MN, 55117-9983, USA

St. Jude Medical, Inc. recieved CE Mark approval of its Brio™ neurostimulator in 2009. Its currently the world’s smallest, longest-lasting rechargeable deep brain stimulation (DBS) device for treating the symptoms of Parkinson’s disease. The Brio is slightly larger than a typical man’s watch, the neurostimulator has a thin 10 mm profile and weighs 29 grams (approximately 1 oz). Th ...
Read More...

ManufacturerSt Jude Medical
Hits731
Updated26 March 2011
Defeat-HF

Medtronic, Inc. (NYSE: MDT) announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry’s first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation (SCS), or neurostimulation, to improve clinical signs and symptoms of he ...
Read More...

ManufacturerMedtronic
Hits613
Updated31 July 2010

USA

Deep brain stimulation is a highly experimental neurosurgical treatment for chronic depression in which the brain is stimulated with electrical impulses. Although it's been approved for several other conditions, deep brain stimulation hasn't been approved by the Food and Drug Administration (FDA) for depression treatment and is in the early stages of research. Requiring brain surger ...
Read More...

ManufacturerMayo Clinic
Hits492
Updated15 November 2009

Follow UpgradeYourBody

FacebookTwitterDiggStumbleuponFeed